Locoregional Stomach Cancer

Gastrointestinal Stromal Tumor

Male, 69 years

Patient Internal ID: 272447331

ICD-10 code

C16.8 Malignant Neoplasm of Overlapping Sites of Stomach

Diagnosis (Incl. Metastases/Stage) and Year

August 2019
Gastrointestinal Stromal Tumor (GIST) ypT4N0(0/12)M0 R0 LV0.

Previous Treatment

Target Therapy (Imatinib), Surgery.

Prognosis and Survival Expectation

The prognosis remains good, the overall 5-year relative survival rate for a GIST in the United States is 85%.

Treatment Provided

Autologous DCV (10 doses) over a period of 16 months.

Patient Survival/Condition and Year
Date of Review: 02/01/2024

The patient has survived for 54 months since the diagnosis and has no signs of disease. It can be concluded that the addition of Immunotherapy, alongside Target Therapy and Surgery, has benefited in disease stabilisation so far.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok